The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I study of niraparib in combination with temozolomide (TMZ) in patients with advanced cancer.
Razelle Kurzrock
No relevant relationships to disclose
Evanthia Galanis
No relevant relationships to disclose
Derek Richard Johnson
No relevant relationships to disclose
Vikram Kansra
Employment or Leadership Position - Tesaro
Keith Wilcoxen
Employment or Leadership Position - Tesaro
Stock Ownership - Tesaro
Ty Mcclure
Employment or Leadership Position - Tesaro
Stock Ownership - Tesaro
Robert E. Martell
Employment or Leadership Position - Tesaro
Stock Ownership - Tesaro
Shefali Agarwal
Employment or Leadership Position - Tesaro
Stock Ownership - Tesaro